Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis

This billing guideline covers molecular testing for identification and management of hereditary transthyretin amyloidosis as governed by MolDX LCD L39950; clinical eligibility details are contained in that LCD. Claims must include the appropriate CPT and ICD-10-CM codes, the required DEX Z-Code entered adjacent to the CPT in the specified Part A/Part B claim fields, and only one test may be billed per patient with 1 unit of service.

"Molecular testing for identification and management of hereditary transthyretin amyloidosis per MolDX LCD L39950."

Sign up to see full coverage criteria, indications, and limitations.